University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Effects of Behavioural Activation on Emotional Cognition and Mood

Not Applicable

Completed

Conditions: Depression
Cognition
Mood Disorders
Depressive Disorder

Interventions: Behavioral: Activity monitoring
Behavioral: Behavioural activation

First Posted Date: 2019-06-21

Last Posted Date: 2023-05-10

Lead Sponsor: University of Oxford

Target Recruit Count: 97

Registration Number: NCT03995186

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: R21 Matrix-M vaccination
Biological: R21 Matrix-M vaccination and CHMI
Biological: R21 Matrix-M vaccination booster

First Posted Date: 2019-06-03

Last Posted Date: 2021-10-13

Lead Sponsor: University of Oxford

Target Recruit Count: 78

Registration Number: NCT03970993

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

and more 1 locations

SMARThealth Pregnancy: Feasibility & Acceptability of a Complex Intervention for High-risk Pregnant Women in Rural India.

Not Applicable

Completed

Conditions: Pre-Eclampsia
Gestational Diabetes
Anemia

Interventions: Other: SMARThealth Pregnancy

First Posted Date: 2019-05-30

Last Posted Date: 2020-11-04

Lead Sponsor: University of Oxford

Target Recruit Count: 258

Registration Number: NCT03968952

Locations: 🇮🇳
The George Institute for Global Health, Hyderabad, Telengana, India

7-day Atorvastatin and Emotional Processing

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Atorvastatin 20mg
Other: Lactose placebo

First Posted Date: 2019-05-29

Last Posted Date: 2020-12-01

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT03966859

Locations: 🇬🇧
Riccardo De Giorgi, Oxford, United Kingdom

Lithium Effects on Reward Processing and Reappraisal in Healthy Volunteers

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: Placebo - Rayotabs
Drug: Lithium

First Posted Date: 2019-05-28

Last Posted Date: 2019-05-28

Lead Sponsor: University of Oxford

Target Recruit Count: 37

Registration Number: NCT03965247

The Effect of D-cycloserine on Emotional Processing

Not Applicable

Completed

Conditions: Healthy Volunteer
Cycloserine

Interventions: Drug: Placebo
Drug: d-cycloserine

First Posted Date: 2019-05-23

Last Posted Date: 2019-05-23

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT03961464

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Placebo oral tablet
Drug: Rivastigmine
Drug: Reboxetine

First Posted Date: 2019-05-21

Last Posted Date: 2020-06-16

Lead Sponsor: University of Oxford

Target Recruit Count: 107

Registration Number: NCT03957174

Locations: 🇬🇧
Dept of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Paired Acute Invasive/Non-invasive Stimulation Trial

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Device: Transcranial direct current stimulation

First Posted Date: 2019-05-17

Last Posted Date: 2020-04-06

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT03954093

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults

Phase 2

Recruiting

Conditions: Malaria,Falciparum

Interventions: Biological: R21/Matrix-M
Biological: ChAd63/MVA ME-TRAP
Biological: intradermal injection (ID) or direct venous injection (DVI) of PfSPZ Challenge

First Posted Date: 2019-05-13

Last Posted Date: 2022-09-15

Lead Sponsor: University of Oxford

Target Recruit Count: 64

Registration Number: NCT03947190

Locations: 🇰🇪
KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast, Kilifi, Kenya

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)

Phase 3

Completed

Conditions: Plasmodium Falciparum Malaria (Uncomplicated)

Interventions: Drug: Artemether-lumefantrine+placebo
Drug: Artesunate-mefloquine+placebo
Drug: Artemether-lumefantrine+amodiaquine
Drug: Artesunate-mefloquine+piperaquine

First Posted Date: 2019-05-06

Last Posted Date: 2024-03-20

Lead Sponsor: University of Oxford

Target Recruit Count: 103

Registration Number: NCT03939104

Locations: 🇧🇩
Ramu Upazilla Health Complex, Cox's Bāzār, Chittagong, Bangladesh
🇰🇭
Kravanh Referral Hospital, Phnum Kravanh, Pursat, Cambodia
🇰🇭
Siem Pang Health Center, Siem Pang, Stung Treng, Cambodia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy